Customize your experience

You decide what information you want to see on your Sanofi Campus

More about science

Choose a therapeutic area to find related scientific content



Atopic Dermatitis


Nasal Polyps

Rare Diseases


Multiple Sclerosis

Prurigo Nodularis

Latest trends

Explore the most popular scientific articles and videos among Campus Sanofi users


Stay up to date and register for the latest events and view webinar recordings

Support for your patients

Discover the selection of support materials for patients from different therapeutic areas

Sanofi in News

Discover headline news on how Sanofi is engaged with the medical community

Our Products


Enoxaparin Sodium is a low molecular weight heparin (LMWH) that is administered subcutaneously and used as antithrombotic agent.


Alirocumab is a fully human IgG1 monoclonal antibody. It’s a PCSK9 inhibitor that is administered subcutaneously.


Clopidogrel is an inhibitor of platelet aggregation administered orally and indicated for Secondary prevention of atherothrombotic events.


Combination of Rosuvastatin Calcium & Ezetimibe used as adjunct to diet for treatment of Primary Hypercholesterolemia or Homozygous Familial Hypercholesterolemia.


Combination of Insulin Glargine (a basal insulin analog) & Lixisenatide (a GLP-1 receptor agonist) administered subcutaneously.


Is a fully human monoclonal antibody with multiple indications in different therapeutic areas.


Insulin Glargine 100, a long-acting insulin administered subcutaneously and used to treat diabetes mellitus in adults, adolescents and children from the age of 2 years.


AUBAGIO® is a once-daily oral tablet that is indicated for adult patients with relapsing remitting multiple sclerosis (RRMS)


Lemtrada® is a monoclonal antibody produced in mammalian cells (Chinese Hamster Ovary).


Valproate and its valproic acid, sodium valproate, and valproate semisodium forms are medications primarily used to treat epilepsy.


Glimepiride is an orally active hypoglycaemic substance belonging to the sulfonylurea group. It may be used in non-insulin dependent diabetes mellitus.


Irbesartan is a potent, orally active, selective angiotensin-II receptor (type AT1) antagonist. It is expected to block all actions of angiotensin-II mediated by the AT1 receptor, regardless of the source or route of synthesis of angiotensin-II used to Effectively control Hypertension to normal Rates.

▼This drug is subject to additional monitoring, the reporting of suspected adverse reactions associated with this drug is a priority.